These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vulvar intraepithelial neoplasia p53 expression, p53 gene mutation and HPV in recurrent/progressive cases. Chulvis do Val IC; Almeida Filho GL; Valiante PM; Gondim C; Takiya CM; Carvalho Mda G J Reprod Med; 2004 Nov; 49(11):868-74. PubMed ID: 15603096 [TBL] [Abstract][Full Text] [Related]
3. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Srodon M; Stoler MH; Baber GB; Kurman RJ Am J Surg Pathol; 2006 Dec; 30(12):1513-8. PubMed ID: 17122506 [TBL] [Abstract][Full Text] [Related]
4. Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia. Hillemanns P; Wang X Gynecol Oncol; 2006 Feb; 100(2):276-82. PubMed ID: 16300821 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infections and vulvar disease development. Garland SM; Insinga RP; Sings HL; Haupt RM; Joura EA Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1777-84. PubMed ID: 19505910 [TBL] [Abstract][Full Text] [Related]
6. Anal human papillomavirus infection and squamous neoplasia in patients with invasive vulvar cancer. Ogunbiyi OA; Scholefield JH; Robertson G; Smith JH; Sharp F; Rogers K Obstet Gynecol; 1994 Feb; 83(2):212-6. PubMed ID: 8290182 [TBL] [Abstract][Full Text] [Related]
7. [Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region]. Hadzić B; Djurdjević S; Hadzić M; Jerant-Patić V Med Pregl; 1998; 51(5-6):265-70. PubMed ID: 9720356 [TBL] [Abstract][Full Text] [Related]
8. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Hampl M; Sarajuuri H; Wentzensen N; Bender HG; Kueppers V Obstet Gynecol; 2006 Dec; 108(6):1361-8. PubMed ID: 17138767 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for cervical neoplasia in Denmark. Kjaer SK APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758 [TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. Goffin F; Mayrand MH; Gauthier P; Alobaid A; Lussier C; Provencher D; Drouin P; Franco EL; Coutlée F J Med Virol; 2006 Jun; 78(6):814-9. PubMed ID: 16628584 [TBL] [Abstract][Full Text] [Related]
12. Tenascin in preinvasive lesions of the vulva and vulvar cancer. Goepel C; Stoerer S; Koelbl H Anticancer Res; 2003; 23(6C):4587-91. PubMed ID: 14981900 [TBL] [Abstract][Full Text] [Related]
13. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Jones RW; Rowan DM Obstet Gynecol; 1994 Nov; 84(5):741-5. PubMed ID: 7936504 [TBL] [Abstract][Full Text] [Related]
14. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Skapa P; Zamecnik J; Hamsikova E; Salakova M; Smahelova J; Jandova K; Robova H; Rob L; Tachezy R Am J Surg Pathol; 2007 Dec; 31(12):1834-43. PubMed ID: 18043037 [TBL] [Abstract][Full Text] [Related]
16. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Al-Ghamdi A; Freedman D; Miller D; Poh C; Rosin M; Zhang L; Gilks CB Gynecol Oncol; 2002 Jan; 84(1):94-101. PubMed ID: 11748983 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus, Epstein-Barr virus and p53 mutation in vulvar intraepithelial neoplasia. Almeida G; do Val I; Gondim C; Lima R; Takiya C; Carvalho G J Reprod Med; 2004 Oct; 49(10):796-9. PubMed ID: 15568402 [TBL] [Abstract][Full Text] [Related]
18. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670 [TBL] [Abstract][Full Text] [Related]
19. The predominance of human papillomavirus type 16 in vulvar neoplasia. Buscema J; Naghashfar Z; Sawada E; Daniel R; Woodruff JD; Shah K Obstet Gynecol; 1988 Apr; 71(4):601-6. PubMed ID: 2832795 [TBL] [Abstract][Full Text] [Related]